The JV company, Granules-Omnichem Pvt. Ltd, will construct a $20 million production facility in the Jawaharlal Nehru Pharma City special economic zone in Visakhapatnam, Andhra Pradesh, to initially manufacture high-value and low-volume products, executives from the two companies said at a press conference in Hyderabad.

Now to return to the not-mattering part: The 500 was always destined to be a low-volume, niche product that marketed itself up from below—virally, if you will, from street to street and from one sorority house to another.